Susquehanna International Group
FRTX

Susquehanna International Group’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Susquehanna International Group’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,273
Closed -$153K – 11080
2019
Q4 		$153K Sell
2,273
-3,554
-61% -$411K ﹤0.01% 8937
2019
Q3 		$1.09M Buy
5,827
+5,481
+1,584% +$1.26M ﹤0.01% 5512
2019
Q2 		$93K Buy
346
+186
+116% +$62.3K ﹤0.01% 9637
2019
Q1 		$60K Sell
160
-30
-16% -$10.1K ﹤0.01% 8428
2018
Q4 		$71K Sell
190
-169
-47% -$66.3K ﹤0.01% 8358
2018
Q3 		$155K Buy
+359
New +$151K ﹤0.01% 8394
2018
Q1 		– Sell
-60
Closed -$35K – 10393
2017
Q4 		$35K Sell
60
-13
-18% -$8.57K ﹤0.01% 9000
2017
Q3 		$55K Sell
73
-55
-43% -$43.5K ﹤0.01% 8521
2017
Q2 		$109K Buy
128
+61
+91% +$44.6K ﹤0.01% 8649
2017
Q1 		$47K Buy
+67
New +$47.2K ﹤0.01% 8611
2016
Q4 		– Sell
-51
Closed -$49K – 10316
2016
Q3 		$49K Sell
51
-5
-9% -$6.31K ﹤0.01% 8127
2016
Q2 		$80K Buy
+56
New +$72K ﹤0.01% 8121
2016
Q1 		– Sell
-18
Closed -$23K – 9839
2015
Q4 		$23K Hold
18
– – ﹤0.01% 9210
2015
Q3 		$25K Hold
18
– – ﹤0.01% 9470
2015
Q2 		$39K Sell
18
-15
-45% -$47K ﹤0.01% 9919
2015
Q1 		$97K Sell
33
-4
-11% -$12.8K ﹤0.01% 8975
2014
Q4 		$121K Buy
37
+2
+6% +$7.08K ﹤0.01% 9120
2014
Q3 		$123K Sell
35
-12
-26% -$46.6K ﹤0.01% 9009
2014
Q2 		$181K Buy
47
+9
+24% +$33.9K ﹤0.01% 9145
2014
Q1 		$154K Buy
+38
New +$170K ﹤0.01% 8403
2013
Q4 		– Sell
-78
Closed -$307K – 9448
2013
Q3 		$307K Buy
78
+17
+28% +$128K ﹤0.01% 7167
2013
Q2 		$598K Buy
+61
New +$676K ﹤0.01% 5789

Other funds holding FRTX

TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group's FRTX Position: Q3 2022 in Review

Susquehanna International Group sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q3 2022, closing a stake of 749 shares — an estimated $4K sold.

Susquehanna International Group first reported a position in FRTX in Q4 2013 and held it in 14 quarters. The position peaked at $78K in Q3 2018. 17 funds tracked by Wall St. Rank hold FRTX as of Q3 2022.

  • Susquehanna International Group reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 749 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • Susquehanna International Group first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • Susquehanna International Group's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $78K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.